Free Trial
→ [Action Required] Claim Your FREE IRS Loophole Guide (From Colonial Metals) (Ad) Buy AKTX Stock  Free AKTX Stock Alerts

Akari Therapeutics (AKTX) SEC Filings & 10K Form

Akari Therapeutics logo
$1.18 +0.07 (+6.11%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Akari Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:00 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
7:50 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM		Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
8:10 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4/A
01/13/2025
7:00 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:05 AM		Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:05 AM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
4:30 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Gaslightwala Abizer (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/26/2024
3:30 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:30 PM		Akari Therapeutics (Issuer)
Hombeck Torsten (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
3:00 PM		Akari Therapeutics (Subject)
Patel Samir Rashmikant (Filed by)
Form SC 13D/A
12/03/2024
4:48 PM		Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:50 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:30 PM		Akari Therapeutics (Issuer)
Huh Hoyoung (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2024
3:30 PM		Akari Therapeutics (Issuer)
Neal James R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Sandip I (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/19/2024
3:48 PM		Akari Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/18/2024
7:02 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Set to Shock the World by May 1st ? (Ad)

Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.

Click here now because after May 1st, it could be too late.
11/14/2024
3:27 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:00 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
5:00 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:51 AM		Akari Therapeutics (Subject)
Form 425
10/14/2024
11:15 PM		Akari Therapeutics (Filer)
Form EFFECT
10/11/2024
3:52 PM		Akari Therapeutics (Filer)
Form 424B3
10/09/2024
3:27 PM		Akari Therapeutics (Filer)
Form S-4/A
10/04/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
5:34 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:43 AM		Akari Therapeutics (Filer)
Form S-4/A
09/18/2024
3:34 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:36 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2024
3:40 PM		Akari Therapeutics (Issuer)
Bazemore Robert B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2024
11:15 PM		Akari Therapeutics (Filer)
Form EFFECT
09/13/2024
4:30 PM		Akari Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
09/06/2024
4:23 PM		Akari Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/06/2024
4:07 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
3:30 PM		Akari Therapeutics (Filer)
Form 8-K/A
08/19/2024
3:30 PM		Akari Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
3:15 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:15 PM		Akari Therapeutics (Filer)
Form NT 10-Q
07/02/2024
3:30 PM		Akari Therapeutics (Issuer)
Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM		Akari Therapeutics (Issuer)
WILLIAMS DONALD A (Reporting)
WILLIAMS DONALD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM		Akari Therapeutics (Issuer)
Hashad Mohamed Wa'el Ahmed (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:30 PM		Akari Therapeutics (Issuer)
Akari Therapeutics (Issuer)
Grissinger Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
6:30 AM		Akari Therapeutics (Subject)
RPC Pharma Ltd (Filed by)
Form SC 13D/A
06/07/2024
5:00 PM		Akari Therapeutics (Subject)
Patel Samir Rashmikant (Filed by)
Form SC 13D
06/04/2024
3:45 PM		Akari Therapeutics (Issuer)
Prudo-Chlebosz Raymond (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:45 PM		Akari Therapeutics (Issuer)
Patel Samir Rashmikant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:30 PM		Akari Therapeutics (Subject)
Form 425
06/04/2024
7:02 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
7:05 AM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
3:47 PM		Akari Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
4:27 PM		Akari Therapeutics (Subject)
Form 425
05/01/2024
4:04 PM		Akari Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
8:45 PM		Akari Therapeutics (Issuer)
Jacques Rachelle Suzanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:AKTX) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
America’s Retirement Accounts Are at Risk—Here’s Why
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored